146 related articles for article (PubMed ID: 22048863)
1. Much more than a gene: hereditary breast and ovarian cancer, reproductive choices and family life.
Dekeuwer C; Bateman S
Med Health Care Philos; 2013 May; 16(2):231-44. PubMed ID: 22048863
[TBL] [Abstract][Full Text] [Related]
2. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.
Staton AD; Kurian AW; Cobb K; Mills MA; Ford JM
Fam Cancer; 2008; 7(2):179-86. PubMed ID: 18026853
[TBL] [Abstract][Full Text] [Related]
4. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
[TBL] [Abstract][Full Text] [Related]
5. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.
Menon U; Harper J; Sharma A; Fraser L; Burnell M; ElMasry K; Rodeck C; Jacobs I
Hum Reprod; 2007 Jun; 22(6):1573-7. PubMed ID: 17428877
[TBL] [Abstract][Full Text] [Related]
6. "My funky genetics": BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies.
Werner-Lin A; Rubin LR; Doyle M; Stern R; Savin K; Hurley K; Sagi M
Fam Syst Health; 2012 Jun; 30(2):166-80. PubMed ID: 22709328
[TBL] [Abstract][Full Text] [Related]
7. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
[TBL] [Abstract][Full Text] [Related]
8. [Having a child and PND/PGD access in women with a BRCA1/2 mutation? Different approach whether ill or healthy].
Pellegrini I; Prodromou N; Coupier I; Huiart L; Moretta J; Noguès C; Julian-Reynier C
Bull Cancer; 2014 Nov; 101(11):1001-8. PubMed ID: 25418592
[TBL] [Abstract][Full Text] [Related]
9. Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.
Lodder L; Frets PG; Trijsburg RW; Klijn JG; Seynaeve C; Tilanus MM; Bartels CC; Meijers-Heijboer EJ; Verhoog LC; Niermeijer MF
Am J Med Genet A; 2003 Jun; 119A(3):266-72. PubMed ID: 12784290
[TBL] [Abstract][Full Text] [Related]
10. Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer.
Quinn GP; Vadaparampil ST; King LM; Miree CA; Friedman S
Fam Cancer; 2009; 8(4):441-9. PubMed ID: 19554475
[TBL] [Abstract][Full Text] [Related]
11. High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer.
Quinn GP; Vadaparampil ST; Miree CA; Lee JH; Zhao X; Friedman S; Yi S; Mayer J
Hum Reprod; 2010 Oct; 25(10):2543-50. PubMed ID: 20713415
[TBL] [Abstract][Full Text] [Related]
12. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
[TBL] [Abstract][Full Text] [Related]
13. Attitudes of high-risk women toward preimplantation genetic diagnosis.
Quinn G; Vadaparampil S; Wilson C; King L; Choi J; Miree C; Friedman S
Fertil Steril; 2009 Jun; 91(6):2361-8. PubMed ID: 18440521
[TBL] [Abstract][Full Text] [Related]
14. "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.
Dean M; Rauscher EA
J Genet Couns; 2017 Dec; 26(6):1301-1313. PubMed ID: 28138923
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation.
Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
Genet Test; 2004; 8(1):13-21. PubMed ID: 15140370
[TBL] [Abstract][Full Text] [Related]
16. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors.
Derks-Smeets IA; de Die-Smulders CE; Mackens S; van Golde R; Paulussen AD; Dreesen J; Tournaye H; Verdyck P; Tjan-Heijnen VC; Meijer-Hoogeveen M; De Greve J; Geraedts J; De Rycke M; Bonduelle M; Verpoest WM
Breast Cancer Res Treat; 2014 Jun; 145(3):673-81. PubMed ID: 24748567
[TBL] [Abstract][Full Text] [Related]
17. Characterizing biased cancer-related cognitive processing: relationships with BRCA1/2 genetic mutation status, personal cancer history, age, and prophylactic surgery.
Carpenter KM; Eisenberg S; Weltfreid S; Low CA; Beran T; Stanton AL
Health Psychol; 2014 Sep; 33(9):1003-11. PubMed ID: 23772886
[TBL] [Abstract][Full Text] [Related]
18. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
[TBL] [Abstract][Full Text] [Related]
19. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Seynaeve C; van Geel AN; Tilanus MM; Bartels CC; Verhoog LC; Brekelmans CT; Burger CW; Niermeijer MF
Breast Cancer Res Treat; 2002 May; 73(2):97-112. PubMed ID: 12088120
[TBL] [Abstract][Full Text] [Related]
20. Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.
Evans DG; Lalloo F; Hopwood P; Maurice A; Baildam A; Brain A; Barr L; Howell A
Eur J Surg Oncol; 2005 Dec; 31(10):1112-8. PubMed ID: 16005602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
